August 29, 2023
Nichi-Iko Pharmaceutical and Sandoz said on August 28 that they have agreed to terminate their distribution licensing pact for an Avastin (bevacizumab) biosimilar signed last year, with the Japanese generic maker set to exclusively market the product from October. “We...read more